{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:16:45Z","timestamp":1762431405640},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"58","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,17]]},"DOI":"10.18632\/oncotarget.22003","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T19:03:05Z","timestamp":1508871785000},"page":"98812-98822","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive"],"prefix":"10.18632","volume":"8","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo Qing","family":"Ru","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Li","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Shan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Zhejiang, People's Hospital of Hangzhou Medical College, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-147-1-200707030-00010","article-title":"The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points","volume":"147","author":"Yuen","year":"2007","journal-title":"Ann Intern Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update","volume":"50","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the study of the liver","year":"2012","journal-title":"J Hepatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Jafri","year":"2012","journal-title":"Hepatol Int"},{"key":"5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a sample non-invasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Nelson","year":"2006","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Lok","year":"2003","journal-title":"Hepatology"},{"key":"7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/jclinpath-2011-200044","article-title":"Diagnostic accuracy of transient elastography versus the aspartate transaminase to platelet ratio index in assessment liver fibrosis in chronic hepatitis B","volume":"64","author":"Budihusodo","year":"2011","journal-title":"J Clin Pathol"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Mallet, Dhalluin-Venier, Roussin, Bourliere, Pettinelli, Giry, Vallet-Pichard, Fontaine, Pol. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2008; 29:409\u2013415. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03895.x.","DOI":"10.1111\/j.1365-2036.2008.03895.x"},{"key":"9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jvh.12279","article-title":"APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B","volume":"21","author":"Gordon","year":"2014","journal-title":"J Viral Hepatol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1440-1746.2010.06383.x","article-title":"Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B","volume":"25","author":"Lu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jhep.2011.08.007","article-title":"Relative performance of fibrotest, fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard","volume":"56","author":"Charlotte","year":"2012","journal-title":"J Hepatol"},{"key":"12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-230X-12-14","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B related fibrosis; a leading meta-analysis","volume":"12","author":"Xuan","year":"2012","journal-title":"BMC Gastroenterology"},{"key":"13","doi-asserted-by":"publisher","first-page":"e23077","DOI":"10.1371\/journal.pone.0023077","article-title":"A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B","volume":"6","author":"Yuen","year":"2011","journal-title":"PLoS ONE"},{"key":"14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.20960","article-title":"Prediction of significant fibrosis in HBeAg positive patients with chronic hepatitis B by a noninvasive model","volume":"42","author":"Zhou","year":"2005","journal-title":"Hepatology"},{"key":"15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Lunel","year":"2005","journal-title":"Hepatology"},{"key":"16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2013.03.002","article-title":"Focus: quantitative HBsAg measurement as a new surrogate marker for assessment of hepatic fibrosis in HBsAg+chronic hepatitis","author":"Shouval","year":"2013","journal-title":"B J Hepatol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jhep.2013.01.028","article-title":"Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-na\u00efve, e antigen-positive patients","volume":"58","author":"Marcellin","year":"2013","journal-title":"J Hepatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.26041","article-title":"Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads","volume":"57","author":"Kao","year":"2013","journal-title":"Hepatology"},{"key":"19","doi-asserted-by":"publisher","first-page":"e43087","DOI":"10.1371\/journal.pone.0043087","article-title":"High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B","volume":"7","author":"Yuen","year":"2012","journal-title":"PLos One"},{"key":"20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12072-013-9502-8","article-title":"Comparison of hepatitis B surface antigen and e antigen in predicting liver histology in hepatitis B e antigen-positive chronic hepatitis B patients","volume":"8","author":"Cheng","year":"2014","journal-title":"Hepatol Int"},{"key":"21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Poynard","year":"1996","journal-title":"The METVIR Cooperative Study Group. Hepatology"},{"key":"22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia","volume":"52","author":"Locarnini","year":"2010","journal-title":"J Hepatol"},{"key":"24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.cgh.2014.12.017","article-title":"Serum levels of hepatitis B surface antigen predict severity of fibrosis in patients with E antigen-positive chronic","volume":"13","author":"Liaw","year":"2015","journal-title":"Hepatitis B. Clin Gastro Hepatol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2542","article-title":"New insights into how HBV manipulates the innate immune response to establish acute and persistent infection","volume":"18","author":"Yuan","year":"2103","journal-title":"Antivir Ther"},{"key":"26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0168-8278(90)90069-4","article-title":"Acute exacerbations in Chinese patients with chronic hepatitis B virus infection, incidence, predisposing factors and etiology","volume":"10","author":"Lai","year":"1990","journal-title":"J Hepatol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Bose","year":"2008","journal-title":"Gastroenterology"},{"key":"28","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/hep.22930","article-title":"Liver biopsy finding in chronic hepatitis B","volume":"49","author":"Kleiner","year":"2009","journal-title":"Hepatology"},{"key":"29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evolution of APRI and FIB-4 scoring systems for non-invasion assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Yee","year":"2016","journal-title":"J Hepatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:36:19Z","timestamp":1589207779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":29,"journal-issue":{"issue":"58","published-print":{"date-parts":[[2017,11,17]]}},"alternative-id":["22003","29228729"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22003","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}